Metastatic gastric cancer – focus on targeted therapies
Judith Meza-Junco, Michael B SawyerDepartment of Oncology, Cross Cancer Institute, Edmonton, Alberta, CanadaAbstract: Gastric cancer (GC) is currently the second leading cause of cancer death worldwide; unfortunately, most patients will present with locally advanced or metastatic disease. Despite re...
Guardado en:
Autores principales: | Meza-Junco J, Sawyer MB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/099185f5e7a940028ffa23aae2ec4e4e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted therapy using nanotechnology: focus on cancer
por: Sanna V, et al.
Publicado: (2014) -
Novel microtubule-targeting agents – the epothilones
por: Daniel R Budman, et al.
Publicado: (2008) -
New treatment options in the management of IBD – focus on colony stimulating factors
por: Josué Barahona-Garrido, et al.
Publicado: (2008) -
Application of liposomes in drug development – focus on gastroenterological targets
por: Zhang JX, et al.
Publicado: (2013) -
Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
por: Wang Z, et al.
Publicado: (2012)